SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Stagmo M) "

Sökning: WFRF:(Stagmo M)

  • Resultat 1-10 av 14
  • [1]2Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Labaf, A., et al. (författare)
  • Predictive accuracies of CHA2DS2-VASc and HAS-BLED, and anticoagulation quality in relation to thromboemblism and bleeding in patients with mechanical heart valves
  • 2013
  • Ingår i: European Heart Journal. - : Oxford University Press. - 0195-668X .- 1522-9645. ; 34:Supplement: 1, s. 379-379
  • Tidskriftsartikel (övrigt vetenskapligt)abstract
    • Background: The variability of international normalized ratio (INR) is considered a risk factor in patients with mechanical heart valves (MHV)and INR target range still remains unestablished. CHA2DS2-VASc andHAS-BLED are risk stratification schemas designed for atrial fibrillation. Their ability to discriminate thromboembolism (TE) and bleeding for patients with MHV have never been investigated.Methods: We conducted a complete study of all patients with MHV followed in two centres. A total of 407 and 140 patients respectively were followed between 2008-2011. Data on INR, time in therapeutic range (TTR), variability, CHA2DS2-VASc and HAS-BLED were extracted.Results: The mean (±SD) age in centre 1 and 2 were 70 (14) and 61 (14) respectively. The target INR range for all MHV was 2-4 in centre 1 and 2-3 in centre 2 and mean INR was 2.9 (0.31) and 2.6 (0.19) respectively. The incidence of TE was 3.4 per 100 patient-years in centre 1 and 1.4 per 100 patient-years in centre 2, p=0.035, and for major bleeding 4.9 per 100 patient-years and 1.7 per 100 patient-years respectively, p=0.005. TheHAS-BLED score correlated well with bleeding, with area under the curveof 0.63 (95% confidence interval [CI]: 0.57-0.70). CHA2DS2-VASc had 0.56 (95% CI: 0.48-0.64) for TE. Adding atrial fibrillation as a risk factor did not improve the c statistic. INR variability (SD), comparing the 3rd tertile with the first had (Odds ratio [OR]: 4.05; 95% [CI]: 2.09-7.84) for major bleeding and (OR: 2.01; 95% [CI]: 1.0-3.99) for TE. INR SD was higher with a higher mean INR and target range 2-4 (p<0.001) andindependently predicted bleeding.Conclusion: HAS-BLED predicted bleeding with discriminatory ability similar to previous reports to atrial fibrillation whilst CHA2DS2-VAScpredictive ability for TE was modest. Higher INR intensity is associated with higher variability, which correlates to primarily bleeding, but also TE. Some of the difference between the groups considering TE can be accounted for more significant risk factors in the centre 1 cohort. A more narrow INR target range could be recommended to reduce variability ofanticoagulation.
  •  
8.
  • Segerhag, Ellen, et al. (författare)
  • Accuracy of a Simplified Glucose Measurement Device-The HemoCue Glucose 201RT.
  • 2015
  • Ingår i: Diabetes Technology & Therapeutics. - : Mary Ann Liebert, Inc.. - 1520-9156 .- 1557-8593. ; 17:10, s. 755-758
  • Tidskriftsartikel (refereegranskat)abstract
    • Easily available, accurate glucose recordings are important when screening for and managing people with diabetes. The photometric HemoCue(®) (Ängelholm, Sweden) Glucose 201+ system, which delivers lab-comparable glucose recordings, has the drawback that its microcuvettes must be delivered and stored at 4-8°C. A newly developed system, HemoCue Glucose 201RT, has microcuvettes that can be stored at room temperature.
  •  
9.
  • Stagmo, M., et al. (författare)
  • The Swedish national programme for quality control of secondary prevention of coronary artery disease - Results after one year
  • 2004
  • Ingår i: European Journal of Cardiovascular Prevention & Rehabilitation. - : Lippincott Williams & Wilkins. - 1741-8267 .- 1741-8275. ; 11:1, s. 18-24
  • Forskningsöversikt (refereegranskat)abstract
    • Background: Guidelines for the prevention of coronary artery disease (CAD) have been developed both in Europe and in the USA. However, several surveys have shown that these guidelines are poorly implemented in clinical practice. Design/methods: The Swedish Quality Control Programme on Secondary Prevention of CAD includes patients after myocardial infarction, or having undergone coronary artery surgery or percutaneous coronary intervention. Fifty of Sweden's 79 hospital districts are currently participating. Patients are asked to send report-cards regarding risk factor management to a central registry after discharge from hospital, at a 3-6 month visit and then yearly for 5 years. Results: Results based on data from 1 year after the index event show that a majority of patients reach targets for serum cholesterol (70%), and low-density lipoprotein (LDL)-cholesterol (71%). Mean value for total cholesterol is 4.6 (± SD 0.9) mmol/l, LDL-cholesterol 2.7 (± SD 0.8) mmol/l. Blood pressure targets are less often achieved, with 58% reaching the European Society of Cardiology target for systolic (< 140 mmHg) and 81% for diastolic (< 90 mmHg) blood pressure. A large proportion of patients are prescribed preventive drugs: aspirin (96%), beta-blockers (78%) and lipid-lowering drugs (83%). Conclusions: The Swedish Quality Control Programme is one of the first attempts to assess implementation of guidelines on a national level based on patient participation. It is hoped that shared care programmes and increased patient involvement with feedback on achieved treatment goals in relation to guidelines will improve outcomes in patients with CAD. © 2004 The European Society of Cardiology.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 14
  • [1]2Nästa
 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy